https://pharmadog.xyz/news/235338 pharmadog en 2026-08-12T18:17:06.000Z Vaccine makers say splitting MMR vaccine is impractical despite presidential directive https://pharmadog.xyz/news/235243 pharmadog en 2026-08-12T18:03:06.000Z WHO calls Trump’s vaccine policy order misguided, warns it could increase needle shots and disease risk for children https://pharmadog.xyz/news/235062 pharmadog en 2026-08-12T17:26:54.000Z FDA outlines new onshoring incentives and meeting types for generic drug applicants under GDUFA IV https://pharmadog.xyz/news/234963 pharmadog en 2026-08-12T16:38:05.000Z Eli Lilly sues six U.S. firms over alleged black-market sales of investigational drug retatrutide https://pharmadog.xyz/news/234687 pharmadog en 2026-08-12T15:43:32.000Z Endpoints News recaps Boston China biotech debate on industry’s China outlook https://pharmadog.xyz/news/234688 pharmadog en 2026-08-12T15:25:55.000Z AbCellera, Silence and InduPro secure major funding rounds as AbCellera completes $200M share sale https://pharmadog.xyz/news/234791 pharmadog en 2026-08-12T15:19:00.000Z Eli Lilly sues to curb black-market sales of experimental obesity drug retatrutide https://pharmadog.xyz/news/234731 pharmadog en 2026-08-12T15:14:02.000Z Deaths reported after treatment with Neurocrine’s approved Prader-Willi drug https://pharmadog.xyz/news/234584 pharmadog en 2026-08-12T15:00:00.000Z Study finds cancer patients now wait longer for treatment than a decade ago https://pharmadog.xyz/news/234585 pharmadog en 2026-08-12T14:51:09.000Z Postpartum psychiatry remains inadequately understood, case of Lindsay Clancy highlights gaps https://pharmadog.xyz/news/234604 pharmadog en 2026-08-12T14:33:00.000Z Definium's LSD pill shows positive results in late-stage anxiety trial https://pharmadog.xyz/news/123087 pharmadog en 2026-08-12T14:14:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/234347 pharmadog en 2026-08-12T14:09:01.000Z Definium’s oral LSD candidate DT120 shows strong anxiety reduction in Phase 3 trial https://pharmadog.xyz/news/234268 pharmadog en 2026-08-12T13:45:25.000Z Eli Lilly sues six U.S. entities over illegal retatrutide sales, urges broader crackdown https://pharmadog.xyz/news/234269 pharmadog en 2026-08-12T13:27:10.000Z 7 companies hiring in North Carolina now https://pharmadog.xyz/news/234288 pharmadog en 2026-08-12T13:22:37.000Z STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more https://pharmadog.xyz/news/234407 pharmadog en 2026-08-12T13:11:00.000Z Silence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccines https://pharmadog.xyz/news/233875 pharmadog en 2026-08-12T12:09:15.000Z Inside a Secret AI Startup: Challenges of Building and Selling Clinical Tools https://pharmadog.xyz/news/233876 pharmadog en 2026-08-12T12:01:16.000Z Definium's LSD pill shows significant anxiety reduction in Phase 3 trial https://pharmadog.xyz/news/233855 pharmadog en 2026-08-12T11:39:51.000Z Sentynl inks up to $475M licensing deal to commercialize Mereo’s alvelestat for rare lung disease https://pharmadog.xyz/news/233856 pharmadog en 2026-08-12T11:30:51.000Z BridgeBio’s ATTR drug Attruby posts strong Q2 sales surge as Alnylam trims Amvuttra outlook https://pharmadog.xyz/news/233595 pharmadog en 2026-08-12T11:00:54.000Z Definium's oral LSD candidate passes first Phase 3 trial in generalized anxiety disorder https://pharmadog.xyz/news/233478 pharmadog en 2026-08-12T10:30:11.000Z Boulevard Bio raises $65M to expand immunology pipeline, eyes Vera's IgAN candidate https://pharmadog.xyz/news/233522 pharmadog en 2026-08-12T10:30:00.000Z Renowned autoimmune researcher Georg Schett co-founds biotech to develop antibody therapies https://pharmadog.xyz/news/233659 pharmadog en 2026-08-12T10:30:00.000Z Boulevard Bio launches with $65 million to develop bispecific antibodies for IgA nephropathy and other autoimmune diseases https://pharmadog.xyz/news/233502 pharmadog en 2026-08-12T10:21:34.000Z Replimune secures FDA approval for RP1 therapy in advanced melanoma as Eli Lilly reports strong Q2 earnings https://pharmadog.xyz/news/234170 pharmadog en 2026-08-12T09:04:00.000Z After slimming down workforce, Aardvark scraps phase 3 trials as wait for next steps drags on https://pharmadog.xyz/news/233148 pharmadog en 2026-08-12T08:30:00.000Z Climate change worsens symptoms for people with chronic illnesses, author reports from Chicago smoke events https://pharmadog.xyz/news/233149 pharmadog en 2026-08-12T08:30:00.000Z Commure's AI-driven referral program draws complaints of financial losses from health-care customers https://pharmadog.xyz/news/233147 pharmadog en 2026-08-12T08:30:00.000Z Neurocrine's Prader-Willi drug Vykat XR linked to multiple deaths and serious side effects https://pharmadog.xyz/news/234062 pharmadog en 2026-08-12T08:06:00.000Z Samsung gets FDA clearance for Galaxy Buds hearing-aid features https://pharmadog.xyz/news/232743 pharmadog en 2026-08-12T07:00:00.000Z Missed promotion often reflects organizational timing, not personal failure https://pharmadog.xyz/news/232103 pharmadog en 2026-08-12T05:38:00.000Z AI-focused biotech firms drive biopharma toward a 'fail-fast' drug development model https://pharmadog.xyz/news/231119 pharmadog en 2026-08-11T22:30:00.000Z French study finds stopping statins in low-risk adults over 75 does not raise mortality https://pharmadog.xyz/news/231120 pharmadog en 2026-08-11T22:18:55.000Z Medicaid to End Funding for Gender-Affirming Surgeries and Hormone Therapy for Transgender Youth https://pharmadog.xyz/news/233078 pharmadog en 2026-08-11T19:52:00.000Z Combination therapy including leronlimab clears HIV in infant macaques, offering new cure hope https://pharmadog.xyz/news/230082 pharmadog en 2026-08-11T18:29:51.000Z Researchers suspect Exelixis used a minor tweak to cabozantinib to sidestep patent cliff https://pharmadog.xyz/news/230083 pharmadog en 2026-08-11T18:25:36.000Z AbbVie, Novartis and Bristol Myers Squibb sue Illinois over 340B drug discount law https://pharmadog.xyz/news/233570 pharmadog en 2026-08-11T17:27:00.000Z Definium's LSD-based therapy shows strong Phase 3 results in generalized anxiety disorder https://pharmadog.xyz/news/229751 pharmadog en 2026-08-11T16:57:34.000Z Health industry pushes back against Trump’s vaccine executive order https://pharmadog.xyz/news/229752 pharmadog en 2026-08-11T16:46:06.000Z Trump’s vaccine executive order likely erodes public trust, says epidemiologist https://pharmadog.xyz/news/229535 pharmadog en 2026-08-11T16:12:00.000Z Former Legend Biotech CEO Ying Huang appointed head of K2 Therapeutics as startup secures $50M seed funding https://pharmadog.xyz/news/229431 pharmadog en 2026-08-11T15:47:19.000Z Health insurers' AI spending meets reality check as UnitedHealth pledges $1.5 billion and CVS outlines its own budget https://pharmadog.xyz/news/229545 pharmadog en 2026-08-11T15:06:00.000Z Henkel recalls Schwarzkopf Professional Osis Grip mousse in U.S. over packaging leak risk https://pharmadog.xyz/news/229215 pharmadog en 2026-08-11T14:44:13.000Z Eli Lilly fronts $2 billion for vaccine biotech deals as Infinimmune secures $75 million funding https://pharmadog.xyz/news/229142 pharmadog en 2026-08-11T14:28:57.000Z Experts warn splitting MMR vaccine into separate shots could increase missed doses and illness https://pharmadog.xyz/news/234910 pharmadog en 2026-08-11T14:26:00.000Z Frankie's Organic Issues Allergy Alert on Undeclared Milk in Frankie’s Organic Plant-Based Vegan Cheddar Puffs https://pharmadog.xyz/news/134233 pharmadog en 2026-08-11T14:21:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/229143 pharmadog en 2026-08-11T14:19:47.000Z Trump pushes controversial changes to MMR vaccine policy, eclipsing new food additive rule https://pharmadog.xyz/news/228983 pharmadog en 2026-08-11T13:55:51.000Z FDA issues complete response letter rejecting ITM Isotope's radiopharma therapy over manufacturing concerns https://pharmadog.xyz/news/230057 pharmadog en 2026-08-11T13:42:00.000Z Amgen to open new R&D Science and Innovation Center in Hyderabad's Genome Valley by 2027 https://pharmadog.xyz/news/229043 pharmadog en 2026-08-11T13:40:00.000Z Infinimmune secures $75 million Series A to develop longer-lasting eczema antibody therapies https://pharmadog.xyz/news/229003 pharmadog en 2026-08-11T13:27:20.000Z FDA rejects ITM Isotope's radiopharmaceutical therapy over manufacturing problems, halting potential competitor to Novartis https://pharmadog.xyz/news/228767 pharmadog en 2026-08-11T13:15:49.000Z Nurses voice concerns on AI while regulators outline RAPID pathway for breakthrough devices https://pharmadog.xyz/news/233453 pharmadog en 2026-08-11T13:12:00.000Z Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs https://pharmadog.xyz/news/228723 pharmadog en 2026-08-11T13:00:25.000Z Hims & Hers says it can quickly launch six wellness peptides if FDA lifts ban https://pharmadog.xyz/news/228747 pharmadog en 2026-08-11T12:59:56.000Z Scholar Rock pulls Indiana fill-finish plant from SMA therapy filing after FDA flags violations https://pharmadog.xyz/news/228724 pharmadog en 2026-08-11T12:54:59.000Z Epicrispr raises $90 million Series C after promising early data on epigenetic FSHD therapy https://pharmadog.xyz/news/228748 pharmadog en 2026-08-11T12:14:53.000Z Insilico Medicine CEO touts billions in pipeline deals at BIO International Convention https://pharmadog.xyz/news/228599 pharmadog en 2026-08-11T12:01:00.000Z Epicrispr and Infinimmune secure $165 million in venture funding for epigenetic and antibody programs https://pharmadog.xyz/news/228555 pharmadog en 2026-08-11T12:00:44.000Z Former Legend Biotech chief Ying Huang named CEO of K2, targets $250 million Series A to license Asian assets https://pharmadog.xyz/news/228619 pharmadog en 2026-08-11T12:00:00.000Z Skylark Bio launches first-in-human gene therapy trial targeting deafness https://pharmadog.xyz/news/228659 pharmadog en 2026-08-11T12:00:00.000Z Epicrispr raises $90 million to push epigenetic editing drug EPI-321 for rare muscle disorder FSHD https://pharmadog.xyz/news/229045 pharmadog en 2026-08-11T11:43:00.000Z Trump signs executive order to split MMR vaccine and reduce U.S. childhood immunization schedule https://pharmadog.xyz/news/228471 pharmadog en 2026-08-11T11:10:09.000Z AbCellera’s antibody ABCL635 cuts hot flash frequency in early trial, outperforms oral competitors https://pharmadog.xyz/news/228304 pharmadog en 2026-08-11T11:01:03.000Z Silence causes uproar in rare blood cancer space as data sets high bar for competitors https://pharmadog.xyz/news/228231 pharmadog en 2026-08-11T11:00:15.000Z Swiss startup Vaderis raises $152 million to fund Phase 3 trial of rare bleeding disorder therapy https://pharmadog.xyz/news/228344 pharmadog en 2026-08-11T11:00:00.000Z Vaderis raises $152 million to launch late-stage trials of AKT inhibitor engasertib for rare bleeding disorder https://pharmadog.xyz/news/228305 pharmadog en 2026-08-11T11:00:00.000Z Vaderis raises $152M Series B to launch Phase 3 trial of engasertib for hereditary hemorrhagic telangiectasia https://pharmadog.xyz/news/229190 pharmadog en 2026-08-11T09:56:00.000Z Epicrispr secures $90M Series C to advance epigenetic therapy for rare muscle disease https://pharmadog.xyz/news/229073 pharmadog en 2026-08-11T09:38:00.000Z Zydus Sentynl signs up to $475M deal to license Mereo's phase-3 ready rare lung disease drug alvelestat in U.S. https://pharmadog.xyz/news/227835 pharmadog en 2026-08-11T08:30:00.000Z Abortion care shifts to remote and private channels as patients seek help outside clinics https://pharmadog.xyz/news/227834 pharmadog en 2026-08-11T08:30:00.000Z Medicare’s new $50 GLP‑1 weight‑loss drug program may create barriers for patients, warns experts https://pharmadog.xyz/news/227833 pharmadog en 2026-08-11T08:30:00.000Z Nurses push for involvement as AI threatens jobs and patient care https://pharmadog.xyz/news/227836 pharmadog en 2026-08-11T08:30:00.000Z Nonprofit North Star Review Board offers independent model to fix IRB oversight issues https://pharmadog.xyz/news/227832 pharmadog en 2026-08-11T08:30:00.000Z MoonLake Immunotherapeutics’ vague data on its autoimmune candidate draws criticism https://pharmadog.xyz/news/228916 pharmadog en 2026-08-11T08:18:00.000Z Aura Biosciences cuts 20% of staff and reshuffles C-suite to focus on ocular oncology https://pharmadog.xyz/news/227379 pharmadog en 2026-08-11T07:00:00.000Z Austria launches up to €100 million anchor investment for growth fund, aiming to channel half‑billion euros into biotech https://pharmadog.xyz/news/230500 pharmadog en 2026-08-11T04:00:00.000Z Hamilton Medical issues recall of coaxial breathing circuit sets for C1, T-1 and MR1 ventilators https://pharmadog.xyz/news/228787 pharmadog en 2026-08-11T03:19:00.000Z Abbott partners with Google Health to add AI-driven insights to its Lingo glucose wearable https://pharmadog.xyz/news/232027 pharmadog en 2026-08-11T00:00:00.000Z FDA rejects ITM radiopharma therapy while WHO defends immunization schedules https://pharmadog.xyz/news/232025 pharmadog en 2026-08-11T00:00:00.000Z PIC/S releases revised guide on qualification and validation studies for pharma manufacturing https://pharmadog.xyz/news/232026 pharmadog en 2026-08-11T00:00:00.000Z Drug makers and animal testing groups urge FDA to keep flexible guidance on animal studies for cancer drugs https://pharmadog.xyz/news/225063 pharmadog en 2026-08-10T20:32:45.000Z Trump orders MMR vaccine to be administered as three separate shots, citing autism concerns https://pharmadog.xyz/news/224723 pharmadog en 2026-08-10T19:29:51.000Z Trump administration issues executive order questioning childhood vaccine schedule https://pharmadog.xyz/news/224679 pharmadog en 2026-08-10T19:05:00.000Z FDA rejects ITM's radiopharma drug for neuroendocrine tumors over manufacturing issues